{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T10:40:58Z","timestamp":1774262458542,"version":"3.50.1"},"reference-count":41,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"7","license":[{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,2]]},"abstract":"<jats:sec>\n            <jats:title>Abstract<\/jats:title>\n            <jats:p>Coronary heart disease (CHD), one of the leading causes of death in the world, is a complex metabolic disorder due to genetic and environmental interactions. The potential mechanisms and diagnostic biomarkers for different types of coronary heart disease remain unclear. Metabolomics is increasingly considered to be a promising technology with the potential to identify metabolomic features in an attempt to distinguish the different stages of CHD.<\/jats:p>\n            <jats:p>We aimed to investigate serum metabolite profiling between CHD patients and normal coronary artery (NCA) subjects and identify metabolic biomarkers associated with CHD progression in an ethnic Hakka population in southern China.<\/jats:p>\n            <jats:p>Using a novel targeted metabolomics approach, we explored the metabolic characteristics of CHD patients. Blood samples from 302 patients with CHD and 59 NCA subjects were collected that analyses using targeted liquid-chromatography coupled with tandem mass spectrometry (LC-MS).<\/jats:p>\n            <jats:p>A total of 361 blood samples were determined using targeted LC-MS. Plasma concentrations for trimetlylamine oxide (TMAO), choline, creatinine, and carnitine were significantly higher in patients with CHD compared to the NCA cohort. Further, we observed that the concentration of the 4 metabolites were higher than that of the NCA group in any group of CHD, which including acute myocardial infarction (AMI), unstable angina (UA), and stable angina (SA). In addition, the diagnostic model was constructed based on the metabolites identified and the ROC curve of the NCA subjects and CHD patients were performed. For choline and creatinine, the AUCs ranged from 0.720 to 0.733. For TMAO and carnitine, the AUCs ranged from 0.568 to 0.600.<\/jats:p>\n            <jats:p>In conclusion, the current study illustrates the distribution of 4 metabolites between CHD patients and NCA subjects. Metabolomics analysis may yield novel predictive biomarkers that will potentially provide value for clinical diagnosis of CHD.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/md.0000000000014309","type":"journal-article","created":{"date-parts":[[2019,2,14]],"date-time":"2019-02-14T05:59:03Z","timestamp":1550123943000},"page":"e14309","source":"Crossref","is-referenced-by-count":24,"title":["Targeted metabolomic analysis of plasma metabolites in patients with coronary heart disease in southern China"],"prefix":"10.1097","volume":"98","author":[{"given":"Zhixiong","family":"Zhong","sequence":"first","affiliation":[{"name":"Center for Cardiovascular Diseases, Meizhou People's Hospital (Huangtang Hospital), Meizhou Academy of Medical Sciences, Meizhou Hospital Affiliated to Sun Yat-sen University"},{"name":"Guangdong Provincial Engineering and Technology Research Center for Molecular Diagnostics of Cardiovascular Diseases"},{"name":"Meizhou Municipal Engineering and Technology Research Center for Molecular Diagnostics of Cardiovascular Diseases"},{"name":"Center for Precision Medicine, Meizhou People's Hospital (Huangtang Hospital), Meizhou Academy of Medical Sciences, Meizhou Hospital Affiliated to Sun Yat-sen University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Liu","sequence":"additional","affiliation":[{"name":"Guangdong Provincial Engineering and Technology Research Center for Molecular Diagnostics of Cardiovascular Diseases"},{"name":"Meizhou Municipal Engineering and Technology Research Center for Molecular Diagnostics of Cardiovascular Diseases"},{"name":"Clinical Core Laboratory, Meizhou People's Hospital (Huangtang Hospital), Meizhou Academy of Medical Sciences, Meizhou Hospital Affiliated to Sun Yat-sen University"},{"name":"Center for Precision Medicine, Meizhou People's Hospital (Huangtang Hospital), Meizhou Academy of Medical Sciences, Meizhou Hospital Affiliated to Sun Yat-sen University"},{"name":"Meizhou Municipal Engineering and Technology Research Center for Molecular Diagnostics of Major Genetic Disorders, Meizhou, PR China."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qifeng","family":"Zhang","sequence":"additional","affiliation":[{"name":"Center for Cardiovascular Diseases, Meizhou People's Hospital (Huangtang Hospital), Meizhou Academy of Medical Sciences, Meizhou Hospital Affiliated to Sun Yat-sen University"},{"name":"Guangdong Provincial Engineering and Technology Research Center for Molecular Diagnostics of Cardiovascular Diseases"},{"name":"Meizhou Municipal Engineering and Technology Research Center for Molecular Diagnostics of Cardiovascular Diseases"},{"name":"Center for Precision Medicine, Meizhou People's Hospital (Huangtang Hospital), Meizhou Academy of Medical Sciences, Meizhou Hospital Affiliated to Sun Yat-sen University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Zhong","sequence":"additional","affiliation":[{"name":"Center for Cardiovascular Diseases, Meizhou People's Hospital (Huangtang Hospital), Meizhou Academy of Medical Sciences, Meizhou Hospital Affiliated to Sun Yat-sen University"},{"name":"Guangdong Provincial Engineering and Technology Research Center for Molecular Diagnostics of Cardiovascular Diseases"},{"name":"Meizhou Municipal Engineering and Technology Research Center for Molecular Diagnostics of Cardiovascular Diseases"},{"name":"Center for Precision Medicine, Meizhou People's Hospital (Huangtang Hospital), Meizhou Academy of Medical Sciences, Meizhou Hospital Affiliated to Sun Yat-sen University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bin","family":"Li","sequence":"additional","affiliation":[{"name":"Center for Cardiovascular Diseases, Meizhou People's Hospital (Huangtang Hospital), Meizhou Academy of Medical Sciences, Meizhou Hospital Affiliated to Sun Yat-sen University"},{"name":"Guangdong Provincial Engineering and Technology Research Center for Molecular Diagnostics of Cardiovascular Diseases"},{"name":"Meizhou Municipal Engineering and Technology Research Center for Molecular Diagnostics of Cardiovascular Diseases"},{"name":"Center for Precision Medicine, Meizhou People's Hospital (Huangtang Hospital), Meizhou Academy of Medical Sciences, Meizhou Hospital Affiliated to Sun Yat-sen University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cunren","family":"Li","sequence":"additional","affiliation":[{"name":"Center for Cardiovascular Diseases, Meizhou People's Hospital (Huangtang Hospital), Meizhou Academy of Medical Sciences, Meizhou Hospital Affiliated to Sun Yat-sen University"},{"name":"Guangdong Provincial Engineering and Technology Research Center for Molecular Diagnostics of Cardiovascular Diseases"},{"name":"Meizhou Municipal Engineering and Technology Research Center for Molecular Diagnostics of Cardiovascular Diseases"},{"name":"Center for Precision Medicine, Meizhou People's Hospital (Huangtang Hospital), Meizhou Academy of Medical Sciences, Meizhou Hospital Affiliated to Sun Yat-sen University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhidong","family":"Liu","sequence":"additional","affiliation":[{"name":"Center for Cardiovascular Diseases, Meizhou People's Hospital (Huangtang Hospital), Meizhou Academy of Medical Sciences, Meizhou Hospital Affiliated to Sun Yat-sen University"},{"name":"Guangdong Provincial Engineering and Technology Research Center for Molecular Diagnostics of Cardiovascular Diseases"},{"name":"Meizhou Municipal Engineering and Technology Research Center for Molecular Diagnostics of Cardiovascular Diseases"},{"name":"Center for Precision Medicine, Meizhou People's Hospital (Huangtang Hospital), Meizhou Academy of Medical Sciences, Meizhou Hospital Affiliated to Sun Yat-sen University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Min","family":"Yang","sequence":"additional","affiliation":[{"name":"Center for Cardiovascular Diseases, Meizhou People's Hospital (Huangtang Hospital), Meizhou Academy of Medical Sciences, Meizhou Hospital Affiliated to Sun Yat-sen University"},{"name":"Guangdong Provincial Engineering and Technology Research Center for Molecular Diagnostics of Cardiovascular Diseases"},{"name":"Meizhou Municipal Engineering and Technology Research Center for Molecular Diagnostics of Cardiovascular Diseases"},{"name":"Center for Precision Medicine, Meizhou People's Hospital (Huangtang Hospital), Meizhou Academy of Medical Sciences, Meizhou Hospital Affiliated to Sun Yat-sen University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pingsen","family":"Zhao","sequence":"additional","affiliation":[{"name":"Guangdong Provincial Engineering and Technology Research Center for Molecular Diagnostics of Cardiovascular Diseases"},{"name":"Meizhou Municipal Engineering and Technology Research Center for Molecular Diagnostics of Cardiovascular Diseases"},{"name":"Clinical Core Laboratory, Meizhou People's Hospital (Huangtang Hospital), Meizhou Academy of Medical Sciences, Meizhou Hospital Affiliated to Sun Yat-sen University"},{"name":"Center for Precision Medicine, Meizhou People's Hospital (Huangtang Hospital), Meizhou Academy of Medical Sciences, Meizhou Hospital Affiliated to Sun Yat-sen University"},{"name":"Meizhou Municipal Engineering and Technology Research Center for Molecular Diagnostics of Major Genetic Disorders, Meizhou, PR China."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-20230914","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1038\/nature09922","article-title":"Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease","volume":"472","author":"Wang","year":"2011","journal-title":"Nature"},{"key":"R2-20230914","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1016\/j.cjca.2015.06.016","article-title":"The relationship between trimethylamine-N-oxide and prevalent cardiovascular disease in a multiethnic population living in Canada","volume":"31","author":"Mente","year":"2015","journal-title":"Can J Cardiol"},{"key":"R3-20230914","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1038\/nm.3145","article-title":"Intestinal microbiota metabolism of l-carnitine, a nutrient in red meat, promotes atherosclerosis","volume":"19","author":"Koeth","year":"2013","journal-title":"Nat Med"},{"key":"R4-20230914","doi-asserted-by":"crossref","first-page":"326","DOI":"10.3390\/toxins8110326","article-title":"Trimethylamine N-oxide: the good, the bad and the unknown","volume":"8","author":"MT","year":"2016","journal-title":"Toxins"},{"key":"R5-20230914","doi-asserted-by":"crossref","first-page":"555","DOI":"10.7326\/0003-4819-137-7-200210010-00006","article-title":"Association of renal insufficiency with treatment and outcomes after myocardial infarction in elderly patients","volume":"137","author":"Shlipak","year":"2002","journal-title":"Ann Int Med"},{"key":"R6-20230914","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1016\/S0735-1097(00)00582-9","article-title":"Predictors of congestive heart failure in the elderly: the cardiovascular health study \u2606","volume":"35","author":"Gottdiener","year":"2000","journal-title":"J Am Coll Cardiol"},{"key":"R7-20230914","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1373\/clinchem.2009.135962","article-title":"Comparison of cystatin C and creatinine as predictors of cardiovascular events in a community-based elderly population","volume":"56","author":"Beilby","year":"2010","journal-title":"Clin Chem"},{"key":"R8-20230914","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/S0735-1097(01)01450-4","article-title":"Renal insufficiency and cardiovascular events in postmenopausal women with coronary heart disease","volume":"38","author":"Shlipak","year":"2001","journal-title":"J Am Coll Cardiol"},{"key":"R9-20230914","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.atherosclerosis.2014.08.040","article-title":"Creatinine, eGFR and association with myocardial infarction, ischemic heart disease and early death in the general population","volume":"237","author":"Sibilitz","year":"2014","journal-title":"Atherosclerosis"},{"key":"R10-20230914","doi-asserted-by":"crossref","first-page":"15357","DOI":"10.1038\/s41598-017-15737-3","article-title":"Investigation of novel metabolites potentially involved in the pathogenesis of coronary heart disease using a UHPLC-QTOF\/MS-based metabolomics approach","volume":"7","author":"Li","year":"2017","journal-title":"Sci Rep"},{"key":"R11-20230914","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1056\/NEJM199707243370403","article-title":"Plasma homocysteine levels and mortality in patients with coronary artery disease","volume":"337","author":"Nyg\u00e3\u00a5Rd","year":"1997","journal-title":"N Engl J Med"},{"key":"R12-20230914","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1177\/204748730000700507","article-title":"Triglycerides and coronary heart disease: implications of recent clinical trials","volume":"7","author":"Rubins","year":"2000","journal-title":"J Cardiovasc Risk"},{"key":"R13-20230914","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1161\/CIRCGENETICS.109.852814","article-title":"Association of a peripheral blood metabolic profile with coronary artery disease and risk of subsequent cardiovascular events","volume":"3","author":"Shah","year":"2010","journal-title":"Circ Cardiovasc Genet"},{"key":"R14-20230914","doi-asserted-by":"crossref","first-page":"1982","DOI":"10.1093\/eurheartj\/ehs424","article-title":"A diabetes-predictive amino acid score and future cardiovascular disease","volume":"34","author":"Magnusson","year":"2013","journal-title":"Eur Heart J"},{"key":"R15-20230914","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-2261-7-20","article-title":"Usual choline and betaine dietary intake and incident coronary heart disease: the Atherosclerosis Risk in Communities (ARIC) study","volume":"7","author":"Bidulescu","year":"2007","journal-title":"BMC Cardiovasc Disord"},{"key":"R16-20230914","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1053\/j.jrn.2015.02.006","article-title":"Associations of trimethylamine N-oxide with nutritional and inflammatory biomarkers and cardiovascular outcomes in patients new to dialysis","volume":"25","author":"Kaysen","year":"2015","journal-title":"J Renal Nutr"},{"key":"R17-20230914","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1136\/bmj.307.6918.1541","article-title":"Summary of 1993 World Health Organisation-International Society of Hypertension guidelines for the management of mild hypertension. Subcommittee of WHO\/ISH Mild Hypertension Liaison committee","volume":"307","year":"1993","journal-title":"BMJ"},{"key":"R18-20230914","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1002\/bmc.3477","article-title":"Determination of trimethylamine-N-oxide in combination with l-carnitine and \u03b3-butyrobetaine in human plasma by UPLC\/MS\/MS","volume":"29","author":"Grinberga","year":"2015","journal-title":"Biomed Chromatogr"},{"key":"R19-20230914","doi-asserted-by":"crossref","first-page":"2207","DOI":"10.1002\/elps.201500055","article-title":"Rapid LC-MRM-MS assay for simultaneous quantification of choline, betaine, trimethylamine, trimethylamine N-oxide, and creatinine in human plasma and urine","volume":"36","author":"Zhao","year":"2015","journal-title":"Electrophoresis"},{"key":"R20-20230914","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1046\/j.1365-2125.1999.00012.x","article-title":"Frequency of cytochrome P450 CYP2C9 variants in a Turkish population and functional relevance for phenytoin","volume":"48","author":"Aynacioglu","year":"1999","journal-title":"Br J Clin Pharmacol"},{"key":"R21-20230914","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1016\/j.redox.2017.04.032","article-title":"Comprehensive metabolomics identified lipid peroxidation as a prominent feature in human plasma of patients with coronary heart diseases","volume":"12","author":"Lu","year":"2017","journal-title":"Redox Biol"},{"key":"R22-20230914","first-page":"3319717706616","article-title":"Assessment of the procoagulant activity of microparticles and the protein z system in patients undergoing off-pump coronary artery bypass surgery","volume":"69","author":"S\u0142omka","year":"2017","journal-title":"Angiology"},{"key":"R23-20230914","doi-asserted-by":"crossref","first-page":"550","DOI":"10.20452\/pamw.4076","article-title":"Plasma levels of the A subunit of factor XIII in patients undergoing off-pump coronary artery bypass surgery","volume":"127","author":"S\u0142omka","year":"2017","journal-title":"Pol Arch Intern Med"},{"key":"R24-20230914","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1373\/clinchem.2011.169573","article-title":"Metabolomics and cardiovascular biomarker discovery","volume":"58","author":"Rhee","year":"2012","journal-title":"Clin Chem"},{"key":"R25-20230914","first-page":"1281","article-title":"Comprehensive metabolomic characterization of coronary artery diseases","volume":"68","author":"Fan","year":"2016","journal-title":"Sci Found China"},{"key":"R26-20230914","doi-asserted-by":"crossref","first-page":"913S","DOI":"10.3945\/jn.115.219147","article-title":"Intervention trials with the mediterranean diet in cardiovascular prevention: understanding potential mechanisms through metabolomic profiling","volume":"146","author":"M\u00e3","year":"2016","journal-title":"J Nutrit"},{"key":"R27-20230914","doi-asserted-by":"crossref","first-page":"30785","DOI":"10.1038\/srep30785","article-title":"Identification of metabolic biomarkers in patients with type 2 diabetic coronary heart diseases based on metabolomic approach","volume":"6","author":"Liu","year":"2016","journal-title":"Sci Rep"},{"key":"R28-20230914","doi-asserted-by":"crossref","first-page":"3500","DOI":"10.1021\/acs.jproteome.6b00179","article-title":"Quantitative metabolomic profiling of plasma, urine, and liver extracts by 1H NMR spectroscopy characterizes different stages of atherosclerosis in hamsters","volume":"15","author":"Wei","year":"2016","journal-title":"J Proteome Res"},{"key":"R29-20230914","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.talanta.2015.10.070","article-title":"Metabolomic profile related to cardiovascular disease in patients with type 2 diabetes mellitus: A pilot study","volume":"148","author":"Garc\u00edafontana","year":"2016","journal-title":"Talanta"},{"key":"R30-20230914","first-page":"657","article-title":"Proteomics and metabolomics for mechanistic insights and biomarker discovery in cardiovascular disease","volume":"66","author":"Barallobrebarreiro","year":"2013","journal-title":"Rev Esp Cardiol"},{"key":"R31-20230914","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1016\/j.jacc.2016.05.098","article-title":"Caveats of untargeted metabolomics for biomarker discovery","volume":"68","author":"Baig","year":"2016","journal-title":"J Am Coll Cardiol"},{"key":"R32-20230914","first-page":"289","article-title":"Intestinal microbial metabolism of phosphatidylcholine: a novel insight in the cardiovascular risk scenario","volume":"4","author":"Ierardi","year":"2015","journal-title":"Hepatobiliary Surg Nutr"},{"key":"R33-20230914","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1586\/erm.10.2","article-title":"Choline in acute coronary syndrome: an emerging biomarker with implications for the integrated assessment of plaque vulnerability","volume":"10","author":"Danne","year":"2010","journal-title":"Expert Rev Mol Diagn"},{"key":"R34-20230914","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1016\/S0002-9149(03)00149-8","article-title":"Prognostic implications of elevated whole blood choline levels in acute coronary syndromes \u2606","volume":"91","author":"Danne","year":"2003","journal-title":"Am J Cardiol"},{"key":"R35-20230914","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1056\/NEJMoa1109400","article-title":"Intestinal microbial metabolism of phosphatidylcholine and cardiovascular risk","volume":"368","author":"Tang","year":"2013","journal-title":"N Engl J Med"},{"key":"R36-20230914","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1038\/sj.ejcn.1602725","article-title":"Prospective study on dietary intakes of folate, betaine, and choline and cardiovascular disease risk in women","volume":"62","author":"Dalmeijer","year":"2008","journal-title":"Eur J Clin Nutr"},{"key":"R37-20230914","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1177\/2047487314524867","article-title":"Plasma choline, smoking, and long-term prognosis in patients with stable angina pectoris","volume":"22","author":"Schartum-Hansen","year":"2015","journal-title":"Eur J Prev Cardiol"},{"key":"R38-20230914","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1001\/archinte.159.15.1785","article-title":"Prevalence and correlates of elevated serum creatinine levels: the Framingham Heart Study","volume":"159","author":"Culleton","year":"1999","journal-title":"Arch Intern Med"},{"key":"R39-20230914","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1161\/01.STR.28.3.557","article-title":"Serum creatinine concentration and risk of cardiovascular disease: a possible marker for increased risk of stroke","volume":"28","author":"Wannamethee","year":"1997","journal-title":"Stroke"},{"key":"R40-20230914","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1161\/01.ATV.0000201060.47945.cb","article-title":"Uremia-specific effects in the arterial media during development of uremic atherosclerosis in apolipoprotein E-deficient mice","volume":"26","author":"Bro","year":"2006","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"R41-20230914","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-2261-9-10","article-title":"ACE inhibition attenuates uremia-induced aortic valve thickening in a novel mouse model","volume":"9","author":"Simolin","year":"2009","journal-title":"BMC Cardiovasc Disord"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00005792-201902150-00007","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,14]],"date-time":"2023-09-14T19:25:30Z","timestamp":1694719530000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00005792-201902150-00007"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2]]},"references-count":41,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000014309","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,2]]}}}